Today’s AI Top Pick: MNSO

7/2/2026 · Bullish Consensus Reliable Bullish screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Bullish Consensus Reliable BullishMNSOBUY NOW8.6 / 107/2/2026

MINISO (MNSO) is the cleanest setup in this pool because it combines the strongest fundamentals in the screen with a forecast tape that's bullish across every timeframe WITHOUT being extended. Valuation is exceptional: PE 12.86, fwdPE 7.69, PEG 0.16, ROE 18.98%, profit margin 9.06%, and sales YoY +30.5% — you rarely get 30%+ topline growth at a single-digit forward multiple. Analyst recom is 1.19 (near strong-buy) with 63.7% target upside, and bullish_prob is 1.0 with near_term_bullish 1.0. The multi-timeframe forecast is genuinely aligned and the magnitudes are large: 4h fc_mid +60.4% / fc_long +48.45%, 1d fc_short +44.32% / fc_mid +46.02% / fc_long +53.02%, and 1wk fc_mid +43.23%. Critically, the daily position_in_21bar_range is only 43.96% and the weekly is 10.01% (pos), with a weekly drawdown of −36.35% from highs — so you are buying in the middle of the daily range and near the bottom of the weekly range, not chasing a breakout. RSI 42.41 gives room to run before overbought. Contrast this with the two closest competitors. PODD has huge forecasts (1d fc_mid +58%, 4h fc_long +90%) but sits at position 100/100 on 1h/4h/1d — pure chase territory. ADMA has strong fundamentals (PEG 0.31, ROE 43.3, profit margin 32.4%) and monster 4h/1d forecasts, but recent Zacks headline notes the stock is drifting and it's already at pos 92.93 on the daily. WAY is pegged at 100/100/100 across 1h/4h/1d — same chase problem. MNSO uniquely delivers alignment + room. News flow is a positive tiebreaker: MNSO tagged as one of the fastest-growing Asian names, up on Monday, and highlighted as a consumer stock "that could explode." No guidance cut, no legal/regulatory landmine, no dilution. Today is the right entry because the daily forecast expects +44% short-horizon move from a mid-range base — waiting for a deeper pullback risks missing the move, and the current level offers a defined stop just below the 21-bar low.

Entry zone

$11.90–$12.30 (buy into current $12.18 or on a small intraday dip to the 4h VWAP area)

Stop loss

$10.95 (below the weekly 21-bar low; ~10% risk, invalidates the mid-range thesis)

First target

$14.00 (retest of the 21-bar weekly high area, ~+15%)

Longer target

$17.00–$18.00 (consistent with fc_long +48% on 4h and target upside of 63.7% to analyst PT)

Risks

China/Asia consumer sentiment risk — MNSO is ADR-exposed to China discretionary spending; a macro shock or FX move can override fundamentals
Debt/Eq 1.05 is elevated for a retailer, and operMargin 13.77% leaves less cushion if same-store sales soften
Institutional ownership is only 9.96%, meaning limited domestic sponsorship and thinner liquidity vs peers — sharper vol on bad prints
Weekly recent_21bar_pct is −35.26% — the trend is still repairing; a failed reclaim of $12.50 would suggest more base-building needed
1h fc_short is only +0.1% — no immediate momentum burst, so the trade requires patience over a 2–8 week horizon

Honorable mentions

ADMABest fundamentals in the pool (PEG 0.31, ROE 43.3%, profit margin 32.4%, 106% target upside) with 4h fc_long +108% and 1d fc_short +57%. Sits at pos 92.9 on daily so slightly extended intraday, and weekly is beaten down (pos 8.73) — buy on any dip to $8.20.

WAYHealthcare billing platform with recom 1.16, positive 'Silently Taking Over' thesis piece, and 1d/1wk forecasts +33%/+56%. Only knock: pinned at pos 100 across three timeframes — better on a pullback to $20.50.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	MNSO	BUY NOW	8.6	PEG 0.16 with 30% sales growth, all-TF bullish forecasts (1d fc_mid +46%), and daily pos only 44% — best risk/reward in the pool.
2	ADMA	BUY NOW	8.1	ROE 43%, PEG 0.31, 106% target upside; 4h fc_long +108% and 1d fc_short +57% — elite fundamentals with monster forecast.
3	WAY	BUY PULLBACK	7.4	Strong healthcare-billing thesis and 1d fc_long +66%, but pinned at pos 100 on 1h/4h/1d — wait for dip.
4	PODD	BUY PULLBACK	7.2	Huge daily/4h forecasts (+58% mid, +90% long) but at pos 100 on 4h/1d — chasing here is risky.
5	ABT	BUY NOW	6.9	DOJ criminal formula probe ended (clean catalyst), mid-range setup, moderate forecasts +23-27% mid/long.
6	VNT	BUY NOW	6.7	PE 10, ROE 35%, at pos 0 on 1h/4h (not extended), 4h fc_mid +31%; Yahoo 'risky' article is a modest headwind.
7	TRMB	BUY NOW	6.5	recom 1.31, daily fc_mid +31% from pos 60.6 (room to run), fresh product launches.
8	NICE	BUY PULLBACK	6.3	fwdPE 7.49 and weekly fc_mid +97.6% are compelling, but at pos 100 on 1h/1d.
9	MELI	BUY PULLBACK	6.1	Best-in-class LatAm growth (sales +42%) but pinned at pos 100 across 1h/4h/1d and weekly forecast is muted.
10	PNR	BUY NOW	5.9	Zacks upgraded to Buy, 1d fc_short +11%, mid-range setup on 4h.
11	GEHC	BUY NOW	5.7	Reasonable valuation (fwdPE 12), 4h/1d forecasts +20%/+9%, dividend announced.
12	TSCO	BUY PULLBACK	5.6	1d fc_short +28% is huge and pos only 29%, but DA Davidson lowered PT and recom 2.0 is weakest in pool.
13	QTWO	BUY PULLBACK	5.4	8.8% Zacks surge and 1d fc_mid +24%, but pos 100 on 1h/1d and 1h forecast negative.
14	KVYO	BUY PULLBACK	5.3	1wk fc_mid/long +90%/+92% eye-catching but not yet profitable and pos 100 on 1h/4h/1d.
15	ITRI	BUY PULLBACK	5.2	Peg 3.49 stretches valuation; forecasts modest and at pos 100 on 1h/1d.
16	TTEK	BUY PULLBACK	5.1	New Army Corps contract, but PEG 2.54 and pos 92-96 across most TFs.
17	TRI	BUY PULLBACK	5.0	Weekly forecasts +64/+74% but near_term_bullish only 0.4 and Wells lowered PT.
18	KRMN	WAIT	4.9	PE 242 and pos 100 on all TFs; Citi lowered PT — wait for base.
19	LOPE	WAIT	4.8	recom 1.0 is strongest but 1wk forecasts negative and near_term_bullish 0.4.
20	FIGR	WAIT	4.7	P/S 13.79 rich, no perfYear data, 1h fc_short −12% suggests near-term digest of $717M Kiavi deal.
21	WING	BUY PULLBACK	4.6	PEG 1.64 and pos 100 on 1h/4h/1d with 1h fc_short slightly negative — don't chase.
22	STNE	WAIT	4.5	Sales YoY −33.9% and negative operating margin −106% — accounting noise clouds the thesis.
23	CHYM	BUY PULLBACK	4.4	Upgraded to Buy with 70%+ implied upside, but ROE −80% and unprofitable.
24	REGN	WAIT	4.3	FDA PreCheck positive but near_term_bullish only 0.4 and 1wk fc_short negative.
25	NIQ	BUY PULLBACK	4.2	1d fc_long +76% intriguing but ROE −62%, DebtEq 4.17, no weekly data.
26	ALC	WAIT	4.1	PE 40 with ROE only 3.7% — modest forecast doesn't justify the premium.
27	XP	WAIT	3.8	bullish_prob only 0.6 and near_term_bullish 0.2 — signal has faded.
28	MDT	WAIT	3.7	Solid fundamentals but modest forecasts (1d fc_mid ~25%) and mixed setup.
29	BETA	WAIT	3.3	President selling 45K shares is a red flag; no fundamentals to anchor.
30	CPNG	AVOID	3.0	US congressional report / South Korea data breach flap is an active regulatory landmine — pass.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord